Microfragmented Adipose Tissue Injection Beneficial for Knee OA

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 9, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 9, 2024 -- For patients with knee osteoarthritis (KOA), microfragmented adipose tissue (MFAT) injection with arthroscopic surgery is associated with improved midterm clinical outcomes, according to a study published online Dec. 26 in the World Journal of Stem Cells.

Cong-Zi Wu, from the First Affiliated Hospital of Zhejiang Chinese Medical University in Hangzhou, and colleagues examined the efficacy and safety of MFAT with arthroscopic surgery in a randomized multicenter trial conducted in 10 hospitals involving 302 patients with KOA (Kellgren-Lawrence grades 2 to 3). Participants were randomly assigned to MFAT or the control group and received MFAT or hyaluronic acid following arthroscopic surgery, respectively (151 patients in each group).

The researchers found significant differences in changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score (including the three subscale scores), visual analog scale (VAS) pain score, and Lequesne index score at the 24-month mark, as well as when comparing values at the posttreatment visit with baseline. At all follow-ups, consistent, significant decreases in the WOMAC pain scores and VAS scores were seen in the MFAT group compared with the control group. At 12 and 24 months, there were significant differences between the groups in the WOMAC stiffness score, WOMAC function score, and Lequesne index score. At 24 months, the Whole-Organ Magnetic Resonance Imaging Score did not significantly differ between the groups.

"We demonstrated that MFAT injection combined with arthroscopic surgery had better clinical efficacy than the control group for treating KOA at a mid-term follow-up and could be a potential therapeutic approach for patients with KOA," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-10 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords